News Eric Isaacs named as 2017 National Academy of Inventors Fellow Eric D. Isaacs, executive vice president for research, innovation and national laboratories at the University of Chicago has been named as a 2017 fellow of the National Academy of Inventors...
Team Eric Ginsburg, PhD Senior Director, Intellectual Property and Technology Development Senior Director, Intellectual Property and Technology Development
Page Where Are They Now? Episode 3 Episode 3: BenchPrep April 29, 2021 Ashish Rangnekar, MBA ’11, grew up in a sleepy town in India where success looked like a white-collar job, not entrepreneurship. But early on...
Technology A Chimeric Antigen Coreceptor System For Optimized Antigen Targeting A novel chimeric antigen coreceptor system mimicking the CD4/CD8 and TCR interaction to enhance signaling for increased antigen sensitivity to treat B cell malignancies. The unmet need: Solutions for…
News Eric Lefkofsky’s Tempus Will Use Data to Help UChicago Battle Breast Cancer Tempus, the cancer fighting startup from Groupon founder Eric Lefkofsky, wants to give doctors at the University of Chicago data to help better treat breast cancer patients. Read more.
Page Polsky Council The Polsky Council comprises many of the country’s leading entrepreneurs, venture capitalists, and private equity investors, who provide ongoing guidance and support to the Polsky Center.
Technology Potentiating the Microbiome for the Prevention of Enteric Bacterial Infection in Livestock Approximately 1/5 of antibiotic resistant infections in humans can be traced back to food and animals. The incidence of these infections is perpetuated by the widespread prophylactic use of antibiotics…
Technology Type I Interferons For Enhancing Chimeric Antigen Receptor T-Cell Efficacy Method to enhance CAR T-cell efficacy by incorporating low-dose exogenous IFN-α2 into CD19-directed, CD28-costimulated CAR T cells post-transduction during manufacturing boosting cytolytic molecule expression, cytokine secretion, and cytotoxicity while minimizing…
News Midway Poised for Clinical Trials By the end of the year, Midway Pharmaceuticals expects to have successfully navigated the “Valley of Death.” That’s the period of financing between identifying a drug product candidate and getting...
Page Where Are They Now? Episode 5 Episode 5: Foxtrot May 13, 2021 Foxtrot cofounder and CEO Mike LaVitola, MBA ’14, has become expert at hearing “no.” He was not initially accepted into the New Venture Challenge,...
Technology A Potent Glioma Targeting CAR T-Cell With Minimal Off-Target Toxicity IL13Ra2 is a cancer testis antigen that is expressed in 50-80% of glioblastoma cells, has no basal expression in the healthy tissue, and is correlated with poor patient prognosis. Problematically,…
